The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
Studies examining full-thickness wounds in animal models demonstrate BPC-157 significantly accelerates closure rates and improves healing quality
Started with 0.25 mg once daily, injecting about an inch below my elbow near where the pain was worst
Committee members were asked to evaluate BPC-157, which is thought to promote tissue repair, for ulcerative colitis
Light protection Semaglutide degrades when exposed to light, particularly UV light